The NICHD Fetal Growth Study: Twin Gestations
|First Received Date ICMJE||June 8, 2011|
|Last Updated Date||November 22, 2016|
|Start Date ICMJE||May 2011|
|Primary Completion Date||Not Provided|
|Current Primary Outcome Measures ICMJE||Not Provided|
|Original Primary Outcome Measures ICMJE||Not Provided|
|Change History||Complete list of historical versions of study NCT01369940 on ClinicalTrials.gov Archive Site|
|Current Secondary Outcome Measures ICMJE||Not Provided|
|Original Secondary Outcome Measures ICMJE||Not Provided|
|Current Other Outcome Measures ICMJE||Not Provided|
|Original Other Outcome Measures ICMJE||Not Provided|
|Brief Title ICMJE||The NICHD Fetal Growth Study: Twin Gestations|
|Official Title ICMJE||NICHD Fetal Growth Study: Twin Gestations|
-Normal growth and development of twins are important for a healthy pregnancy and the long-term health of the children. This study will look at how twins grow and develop inside the womb. This knowledge may reduce and/or prevent pregnancy and newborn health problems in the future.
-To describe how twins grow.
To describe how identical (from the same egg) and fraternal (from different eggs) twins grow.
-Women from nine U.S. clinical centers who are in the first three months of a twin pregnancy.
Fetal growth is an important determinant of health and disease in the perinatal period, childhood and adult life. NICHD is conducting an ultrasound study in singleton pregnancies to establish a national standard for normal fetal growth by gestation and interval velocities. Twins represent 3.2% of all births in the U.S, and these pregnancies are at increased risk for fetal growth disorders, preterm and, most importantly, very preterm delivery. The rate of small-for-gestational-age (SGA) defined as below the 10th percentile using a singleton birth weight-for-gestational-age reference is 35%. Neonatal morbidity is higher in twin gestations than in singletons (25.6 versus 4 per 1,000), and the infant mortality rate is also higher (31 versus 6.4 per 1,000). Discrepancy in the sizes of twins at birth is a frequent phenomenon, and is associated with an increased risk of perinatal morbidity and mortality.
The trajectory of fetal growth in twins throughout gestation has been observed and described in a few studies, both using ultrasonography and ultrasonography combined with birth weight. The findings suggest a slowing of growth for almost all twins after 28-30 weeks gestation, and even twins who had been growing at rates similar to singletons before 28 weeks may show slowed rates of growth in the third trimester. It has been hypothesized that this pattern of growth for even well-growing twins is a normal down-regulation in response to a constricted uterine environment and may underscore the need for a birth weight-for-gestational-age or ultrasound reference that is specific for twins. As for singleton births, however, such slow-downs later in pregnancy appear to be associated with earlier delivery and a greater risk for morbidity associated with preterm birth. This would argue against a separate reference for twins or, at least, for the development of a growth velocity standard for singletons and twins to allow for the accurate assessment of interval growth to better manage these cases.
We propose to conduct the NICHD Fetal Growth Study Twin Gestations, which is a prospective cohort study with longitudinal measurement of fetal growth conducted in nine clinical centers. Overall, there are four main research objectives: 1) to describe fetal growth trajectories in twins using two- and selected three-dimensional ultrasound measures; 2) to compare and contrast fetal growth trajectories for twins with the newly established fetal growth standard developed for singletons to determine its applicability for monitoring the growth of twin fetuses and discordant growth of the pair; 3) to estimate the incidence of growth restriction (with SGA as a proxy) in singleton and twin gestations (by zygosity), however, growth restriction may be defined by the new growth standard; and 4) to compare singleton and twin gestations with respect to maternal biomarkers of fetal growth, well-being and maternal nutritional status using banked biospecimens to determine if the biomarkers ranges established for singletons are applicable to twin gestations.
This study will recruit 350 pregnant women with a twin gestation from nine clinical centers. The study is designed to enroll approximately 350 dichorionic twin pairs based upon incidence figures for twinning at the population level. Women will be recruited during the first trimester and followed until delivery. Serial ultrasound assessments of fetal growth are the standard of care for twin pregnancies, and we will coordinate the timing of research ultrasounds to the fullest extent possible with clinical scans to minimize exposure as further described in this protocol. Each woman will have seven scheduled ultrasound examinations, including fetal biometry at all visits, fetal Doppler studies, and four blood draws at baseline and at targeted gestational ages for the eventual identification of biomarkers indicative of fetal growth. After delivery, neonatal anthropometric measures will be assessed for each twin, and select information about the obstetrical course and newborn status will be abstracted from medical charts.
|Study Type ICMJE||Observational|
|Study Design ICMJE||Time Perspective: Prospective|
|Target Follow-Up Duration||Not Provided|
|Sampling Method||Not Provided|
|Study Population||Not Provided|
|Intervention ICMJE||Not Provided|
|Study Group/Cohort (s)||Not Provided|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
|Recruitment Status ICMJE||Completed|
|Estimated Enrollment ICMJE||350|
|Completion Date||Not Provided|
|Primary Completion Date||Not Provided|
|Eligibility Criteria ICMJE||
- Expect to deliver at one of the participating hospitals
|Ages||18 Years to 45 Years (Adult)|
|Accepts Healthy Volunteers||Yes|
|Contacts ICMJE||Contact information is only displayed when the study is recruiting subjects|
|Listed Location Countries ICMJE||United States|
|Removed Location Countries|
|NCT Number ICMJE||NCT01369940|
|Other Study ID Numbers ICMJE||999911178, 11-CH-N178|
|Has Data Monitoring Committee||Not Provided|
|Plan to Share Data||Not Provided|
|IPD Description||Not Provided|
|Responsible Party||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|
|Study Sponsor ICMJE||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|
|Collaborators ICMJE||Not Provided|
|Information Provided By||National Institutes of Health Clinical Center (CC)|
|Verification Date||November 2016|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP